Leflunomide an Immunosuppressive Drug for Antiviral Purpose in Treatment for BK Virus-Associated Nephropathy After Kidney Transplantation
نویسنده
چکیده
BK virus is a polyomavirus belonging to the papovaviridae branch. In addition to BK, the human polyomavirus family includes John Cunningham virus (JCV), Washington University virus (WUV), Karolinska Institute virus (KIV) and Merkel cell viruses (Boothpur et al. 2010). BK virus is a virus without a shell and it has a double-stranded circular nonenveloped DNA. It was first discovered and isolated in 1971 just like JC virus, responsible for Progressive Multifocal Leukoencephalopathy (PML). Contamination usually occurs during early childhood through the airway without clinical symptoms. BK virus seroprevalence in general population is around 60%. The main latency areas are the kidney and the urothelium. Asymptomatic BK virus infection is often acquired in childhood and the virus persists in a dormant state in urothelium and kidneys of healthy and immunocompetent individuals, where it can be reactivated under immunosuppression (Nickeleit et al. 2000a; Brocker et al. 2011).
منابع مشابه
BK virus nephropathy and kidney transplantation.
Nephropathy from BK virus (BKV) infection is an evolving challenge in kidney transplant recipients. It is the consequence of modern potent immunosuppression aimed at reducing acute rejection and improving allograft survival. Untreated BKV infections lead to kidney allograft dysfunction or loss. Decreased immunosuppression is the principle treatment but predisposes to acute and chronic rejection...
متن کاملLong-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
OBJECTIVES There is no active treatment for postrenal transplant BK virus-associated nephropathy proven to be effective so far. We assessed the effectiveness of actively treating this condition with combined leflunomide, intravenous immunoglobulin, and ciprofloxacin on long-term graft outcome compared with minimization of immunosuppressive drugs. MATERIALS AND METHODS Kidney transplant recipi...
متن کاملActive management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
OBJECTIVES Thus far, there is no active treatment for BK virus-associated nephropathy after a kidney transplant that has proven to be effective. We sought to assess the effectiveness of treatment with leflunomide, intravenous immunoglobulin, and ciprofloxacin on graft outcome after 1 year compared with a historical group treated with reduced immunosuppressive medications strategy. MATERIALS A...
متن کاملبررسی مولکولی فعالیت مجدد ویروس BK در ادرار بیماران پیوند کلیه
Background & Amis: BK polyomavirus (BKV) is common infection of childhood that persists in kidney epithelium. BKV reactivation characterized by viruria occurs in 35% to 57% of renal allograft recipients. BK virus was detected in serum samples in 6% to 29% of these patients. BKV-associated nephropathy occurs in as many as 8% of renal allograft recipients and may lead to . This study was carri...
متن کاملFirst documented case of BK nephropathy in kidney transplant recipient in Croatia: usage of urine cytology in evaluation process.
BK virus associated nephropathy (BKVAN) in transplanted kidney, although recognized as a distinct entity in the 1970-es, continues to represent a challenge in kidney transplantation, mainly because the optimal treatment approach has not been determined yet. The fact that about 10-20% of patients have simultaneously some stage of acute rejection, complicate the treatment even more. Herein we pre...
متن کامل